Top 10 AI Tools for Doctors

Purpose-built AI clinical assistant that generates structured medical notes from doctor-patient conversations with HIPAA compliance, but limited to documentation rather than clinical decision support.

Nabla demonstrates strong core utility with 85,000+ clinicians and 130+ healthcare organizations confirmed, deep EHR integrations across Epic, Cerner, athenahealth, and others via a public Core API with webhooks and streaming, high accuracy ratings (4.8/5), and clinician testimonials affirming productivity gains; ROI accessibility is the primary drag given opaque pricing around $119/month per provider with no clearly confirmed free tier.

Nabla earns a high trust score backed by a comprehensive security posture (SOC 2, ISO 27001, HIPAA, GDPR, NIST Cybersecurity confirmed at trust.nabla.com), an explicit privacy-first policy stating audio is never stored or used for AI training, a clean public status page history, and strong company stability anchored by a $70M Series C in June 2025 bringing total funding to $120M.

Nabla shows strong market momentum with a $70M Series C led by HV Capital and DST Global (June 2025, within 12 months), 85,000+ clinicians as active users, integrations across major EHR marketplaces including Epic and Cerner, substantive third-party press coverage in Fierce Healthcare and Becker's Hospital Review, and the October 2025 launch of Nabla Connect expanding its EHR ecosystem reach.

Nabla's API infrastructure is mature with versioned regional endpoints (us/eu), OAuth 2.0 auth (Server and User APIs), documented webhooks, transcription WebSocket streaming, and an active changelog; the main gaps are the absence of a confirmed Python SDK (JavaScript sample app is the primary reference) and no explicit LangChain/LlamaIndex framework integration documented.

AI search engine for peer-reviewed medical research that extracts evidence-based findings doctors need for clinical decision-making, but not designed exclusively for medical use cases.

Core task utility is high — confirmed by multiple independent university libraries, a PMC peer-reviewed evaluation, and third-party reviewers praising its accuracy and efficiency for academic search across 220M+ papers; workflow integration covers Zotero, Endnote, Mendeley, ChatGPT plugin, and LibKey but lacks Zapier/Make and a fully public API, holding integration depth to mid-tier; free tier is generous and Pro at $10/mo is competitively priced; onboarding is intuitive with near-zero learning curve per multiple reviewer accounts.

Consensus explicitly opts users out of AI training with no PII stored or shared — confirmed by Bentley, Ohio University, and St. Catherine University library guides — earning a strong privacy score; however, no SOC 2 Type II or equivalent third-party security certification was found, capping security certification; hallucination risk is structurally mitigated by search-before-synthesis architecture and checker models, though misread-source errors remain possible; zero tracked incidents since November 2025 per IsDown, and the $30M round with DJ Patil joining the board signals operational stability.

Exceptional growth: from 400K MAU at Series A (Aug 2024) to 2.5M MAU and 10M+ total users by mid-2026, with 170+ university library partnerships, 6 of the top 12 academic publishers, and active deployment by OSU, UVA, UMD, and others; $30M round led by GreatPoint Ventures in May 2026 with USV doubling down signals strong market conviction; covered by Verdict, PRWeb, and The Business Journals with analytical substance, though coverage remains mostly startup-tier rather than tier-1 tech press.

A public API exists at consensus.app/home/api/ enabling embedding of Consensus search into workflows, but documentation depth, versioning, rate limit specifics, and OpenAPI spec availability were not confirmed; changelog was updated as recently as October 2025 indicating active development; no official Python/JS SDK found; no webhooks or streaming API documented; the tool is primarily a consumer/prosumer SaaS with limited orchestration surface, keeping infrastructure scores in the baseline consumer range.

AI voice assistant specifically built for doctors to generate clinical notes from patient conversations with medical terminology optimization, though slightly less established than Nabla in structured note output.

Suki delivers strong verified clinical utility — KLAS score 93.8, physicians averaging 76% faster note completion across multiple independent hospital ROI reports — but its $299–$399/user/month pricing with no free tier significantly drags the ROI accessibility sub-score.

SOC 2 Type II and HIPAA compliance are confirmed by an American Psychiatric Association vendor inquiry (July 2025), data is deidentified before LLM processing, and the October 2024 Series D plus Zoom Ventures investment signal strong company stability; only minor trust gaps exist around GDPR specificity and absence of a confirmed public status page.

A $168M total raise (Series D Oct 2024 + Zoom Ventures Jan 2025) at a ~$500M valuation, named adoption at Rush, McLeod Health, MedStar, and FMOL, plus Epic App Orchard presence and tier-1 healthcare press coverage collectively signal a well-validated, accelerating market position.

A versioned partner developer platform (developer.suki.ai) with Web SDK now at v2.0.4, ambient session lifecycle APIs, and active release notes reflects solid developer investment, though explicit rate-limit documentation and a second native SDK language were not confirmed, and no public SLA was found.

Knowledge management system that helps doctors organize clinical notes and medical research with powerful linking, but requires significant setup and lacks medical-specific templates.

Obsidian scores strongly on core utility (4.8-star ratings, Bases launched 2025, 4,165+ plugins) and exceptional ROI via its fully-featured free tier, but is dragged down by a well-documented steep learning curve and near-zero native workflow integrations due to its local-first architecture — community webhooks and MCP plugins partially compensate but no official Zapier/Make listing exists.

Local-first architecture with end-to-end encrypted Sync provides genuinely strong privacy (Obsidian staff cannot read vault contents), but the bootstrapped company has no SOC 2 or ISO 27001 certification confirmed, which caps the security posture for enterprise use cases; a public status page exists and no breach history was found.

A 100,000+ member Reddit community and over 4,165 plugins signal robust grassroots adoption, but Obsidian remains bootstrapped with ~$2M ARR and no VC backing, limiting enterprise marketplace presence; independent analytical coverage (2026 Report Card, Zapier, G2 Learn) supports narrative quality.

Development is highly active (v1.12.4 shipped March 2026, changelog current) and the TypeScript plugin API with developer docs at docs.obsidian.md provides a solid extension surface; however, there is no official versioned REST API, no Python/JS SDK, and orchestration relies entirely on community-built MCP servers and webhook plugins rather than official integrations.

General AI assistant excellent at explaining complex medical concepts and drafting patient communications with safety features, but not purpose-built for clinical workflows or documentation.

Claude scores strongly across core utility (praised for low hallucination, exceptional coding and writing), deep workflow integration (Zapier 9,000+ apps, MCP native, Google Workspace), and an accessible freemium model; the only meaningful drag is recurring complaints about usage limits on Pro/Max tiers disrupting paid-user workflows.

SOC 2 Type I & II, ISO 27001:2022, and ISO/IEC 42001:2023 certifications anchor a high security score, and the company's $380B-valuation stability is unmatched, but a September 2025 policy shift to opt-out (rather than opt-in) AI training by default moderates the privacy sub-score.

Anthropic's Series G ($30B, $380B valuation), $5B+ ARR run-rate, 70% Fortune 100 adoption, 40% enterprise LLM spend share, and tier-1 press coverage (Claude Cowork triggering the 'SaaSpocalypse' narrative) make this one of the strongest market profiles in the AI sector.

With official SDKs in 8 languages, Anthropic's own MCP protocol natively integrated, LangChain/LlamaIndex support, a newly released Rate Limits API, and Claude Code showing 586+ commits with changelogs updated within hours, the developer infrastructure is best-in-class.

Free AI meeting recorder that summarizes telemedicine calls and automates note-taking for virtual consultations, but lacks medical terminology optimization and clinical structure.

Fathom earns a near-top operational score driven by a 5.0/5 G2 rating across 6,700+ reviews, an extremely generous free tier with unlimited recording and transcription, a sub-3-minute setup confirmed by multiple independent reviewers, and native integrations with Zoom, HubSpot, Salesforce, Slack, Asana, Close CRM, and Zapier; minor deductions applied for occasional timestamp inaccuracies on long calls and UI distraction complaints.

SOC 2 Type II and GDPR compliance are confirmed, data selling is explicitly denied, and an opt-out from AI training is available to both individual and organization-level users, but a deduction is applied because Fathom uses de-identified customer data for its own proprietary model improvements by default, and the 133 publicly logged outages over 12+ months on the status page—while transparently reported—reflect a non-trivial incident frequency.

Fathom is the #1 most-installed AI app on both the Zoom and HubSpot marketplaces, named to G2's 2026 Best Software Awards Top 100, recognized as HubSpot's 2025 Most Used App of the Year, and grew G2 reviews from ~3,000 to 6,700+ (>100% growth) in under 18 months, with a $17M Series A closed in September 2024 and $30.2M total raised.

Fathom launched a public API (October 2025) with TypeScript and Python SDKs, full webhook support, and a dedicated developer portal at developers.fathom.ai, but the API is relatively new with no confirmed versioning scheme or explicit rate-limit documentation found, and no SLA percentage is publicly stated, holding infrastructure below elite tier.

AI research assistant that finds and summarizes academic papers useful for staying current with medical literature, though generalist design means it lacks medical-specific extraction features.

Elicit scores strongly on core utility (8/10 from multiple independent reviewers, 2M+ users, 125M+ papers) and accessibility (free tier + $12/mo), but takes a -10 G2 penalty for only 1 confirmed G2 review, and output reliability is modestly docked due to a 2025 peer-reviewed Sage Journals study documenting hallucinations in data extraction tasks.

Elicit has a public DPA with GDPR SCCs, a subprocessor list at trust.elicit.com, and a security addendum, but no SOC 2 Type II confirmation was found in search results, no explicit AI training opt-out was publicly confirmed, and no status page with incident history was located, keeping Trust at a cautious 60.

A $22M Series A in February 2025 led by Spark Capital at a $100M valuation, active enterprise adoption (Oxford PharmaGenesis, MicroGenDX), PubMed and ClinicalTrials.gov integrations, and 2M+ monthly users signal strong and accelerating market traction.

The Elicit API launched on March 3, 2026, with a GitHub api-examples repository and an actively maintained changelog updated through May 2026, but the API is very new with no confirmed versioning scheme, SDK availability, or documented rate limits, warranting an -8 penalty and capping the score at 47.

AI search engine that provides cited medical information useful for quick clinical queries, but lacks specialized medical database access and peer-review filtering that doctors require.

Perplexity scores 95–97% ease-of-use on G2, ships 10+ features since Dec 2025 including memory and scheduled searches, offers a robust free tier plus $20/mo Pro, and integrates natively with LangChain, Zapier, and dozens of connectors — strong across all five operational sub-dimensions with only occasional hallucination warnings keeping output reliability below 80.

Zero-data-retention on the Sonar API and explicit no-training policy for enterprise data are strong privacy signals, but SOC 2 Type II is not yet publicly confirmed (only a HIPAA gap assessment and CAIQlite are cited), and active copyright lawsuits from NYT, Chicago Tribune, and Reddit introduce reputational trust risk; Sonar Reasoning Pro holds the #1 Search Arena score and highest SimpleQA F-score (0.858) but a 37% CJR citation hallucination rate tempers the accuracy sub-score.

Perplexity raised $500M in a May 2025 Series E at a $22.6B valuation ($1.72B total), processes 100M+ queries/week, struck a $400M Snapchat integration deal, launched the Comet browser, and ARR grew from $80M to ~$200M by Feb 2026 — all strong signals, offset slightly by ongoing copyright litigation and reputational controversy applying a −5 penalty.

The API platform offers three distinct tiers (Sonar, Search, Agent), LangChain and LlamaIndex integrations are officially documented, the changelog is updated weekly, and a public status page shows 100% uptime over 90 days — the only gap is the absence of an explicit SLA document and a confirmed OpenAPI spec download link, capping platform durability.

General-purpose AI useful for drafting patient communications and explaining medical concepts, but not HIPAA-compliant and lacks clinical documentation features doctors need.

ChatGPT earns a 4.7/5 on G2 and is broadly praised for writing, coding, and research tasks, but a documented pattern of GPT-5.5 quality-decline complaints and reliability reports (1,099 verified user complaints catalogued by mid-2026) pull output reliability and accuracy sub-scores down from elite territory; 60+ native integrations (Slack, GitHub, Google Drive, etc.) and a full public API keep integration depth high.

OpenAI holds SOC 2 Type II, ISO 27001/27017/27018/27701, and CSA STAR certifications with a comprehensive DPA supporting GDPR, CCPA, HIPAA, and FERPA, which anchors the security and privacy sub-scores; however, free-tier users remain subject to training data use without explicit opt-out, and hallucination/accuracy complaints are an ongoing non-trivial theme, moderating the overall trust score.

OpenAI closed a $122B round at an $852B post-money valuation (May 2026) after earlier raising $40B at $300B (April 2025) and $110B at $730B (February 2026), confirming elite funding and stability; ChatGPT's G2 rating of 4.7/5 with hundreds of active recent reviews, confirmed market leadership in consumer AI, and approximately $2B in monthly revenue as of March 2026 make this the strongest market dimension of any AI tool evaluated.

The OpenAI API is fully versioned with complete auth docs, rate-limit documentation, Python and JavaScript SDKs, MCP server support (documented December 2025), and LangChain/LlamaIndex integrations; development cadence is fast with release notes updated through February 2026, though occasional undisclosed model-behavior changes and the lack of a perfectly clean status-page history across 12 months prevent a top-tier infrastructure score.

Flexible workspace with AI writing features useful for medical practice management and patient resources, but generalist design means no HIPAA compliance or clinical optimization.

Notion AI scores strongly on core writing/summarization tasks confirmed across 8+ independent reviews and deep integrations (Zapier 8000+ apps, MCP, native API), but output reliability is docked for documented multi-page synthesis hallucinations (~60% accuracy cross-page) and AI access now gated to the $20/user/mo Business tier.

Explicit no-training-data clause in Notion's published AI security policy, confirmed SOC 2 Type II, GDPR DPA available, and $600M ARR with Sequoia/Coatue backing signal strong stability, though third-party subprocessor data sharing and occasional accuracy issues in synthesis tasks moderate the score.

11,857 G2 reviews with active recent posting, Zapier marketplace presence, named enterprise customers (Vercel), strong independent press and a technical changelog active through May 2026 drive high market scores, partially offset by the last formal funding round being the 2021 Series C (though $600M ARR negates the revenue-signal penalty).

Official versioned SDKs for JavaScript (with 2026-03-11 API version), documented rate limits (3 req/s), a native MCP server, LangChain integration, webhook-capable Workers launched May 2026, and an active GitHub with recent commits deliver a best-in-class infrastructure profile for a productivity SaaS tool.